Carla González de la Cruz

10PUBLICATIONS
16CO-AUTHORS
African languagesPharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)Pacific Peoples linguistics and languagesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Association of Native American, European, and African Ancestry with CYP450 Pharmacogenetics and Metabolic Phenotypes in Admixed Latin American Populations from Ecuador and Nicaragua.

|Sep 26, 2026
Pharmacogenetic, Clinical, Prescribing, and Demographic Predictors of Sertraline Pharmacokinetics.

|Apr 08, 2026
CYP2C:TG haplotype in Ecuador and Nicaragua: insights into CYP2C19 genotype-phenotype correlation in context to Mestizo populations.

Carla González de la Cruz, Catalina Altamirano-Tinoco, Juan Antonio Villatoro-García

|Feb 27, 2026
Influence of CYP2D6, CYP2C19, and CYP2C9 Pharmacogenetics and Clinical Factors on Dose-Normalized Venlafaxine/O-Desmethylvenlafaxine Metabolic Ratio in Spanish Patients.

Levin Thomas, Carla González de la Cruz, Carmen Mata-Martín

|Jan 28, 2026
CYP2C:TG Haplotype in Native Mexicans, Molecular Ancestry and Its Implications for CYP2C19 Genotype-Phenotype Correlation.

Carla González de la Cruz, Nadine de Godoy Torso, Juan Antonio Villatoro-García

|Jan 28, 2026
Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and Clinical Determinants of Fluoxetine-Norfluoxetine Pharmacokinetics in Real-World Clinical Conditions.

Carla González de la Cruz, Levin Thomas, Carmen Mata-Martín

Pageof 2

Frequent Collaborators

9 joint publications

Adrián LLerena

6 joint publications

Fernanda Rodrigues-Soares

4 joint publications

Pedro Dorado

4 joint publications

Juan Antonio Villatoro-García